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ABSTRACT- 
Ambulatory blood pressure monitoring (ABPM) accurately classifies the blood pressure 
(BP) status, but its impact on the prevalence and control of hypertension is little known. We 
conducted a cross-sectional study in 2012 among 1047 individuals aged ≥60 years coming 
from the follow-up of a population cohort in Spain. Three casual BP measurements and 24-h 
ABPM were performed under standardized conditions. Some 68.8% were hypertensive 
based on casual BP (≥140/90 mmHg or current BP medication), and 62.1% under 24-h 
ABPM (≥130/80 or current BP medication) (p=0.009). The proportion of patients with 
treatment-eligible hypertension who met BP goals increased from 37.4% under casual BP 
target to 54.1% under the 24-h BP target (absolute difference 16.7%, p<0.01). These results 
were consistent across alternative BP thresholds. Therefore, compared with the casual BP, 
the 24-h ABPM led to a reduction in the proportion of older subjects recommended for 
hypertension treatment and a substantial increase in the proportion of those with 
hypertension control.  
 
KeyWords: hypertension; control; prevalence; ambulatory blood pressure monitoring; 
epidemiology; aged.  
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High blood pressure (BP) poses a serious cardiovascular risk to the individual and a big 
burden to the population.
1-3
 Casual BP determined in the office or clinic has been the 
standard of measurement during many decades. However, ambulatory BP monitoring 
(ABPM) can provide an estimate of the true, or mean, BP level and predicts clinical 
outcomes better than conventional BP measurements.
4-7 
Although there are many studies on the epidemiology of hypertension using both in-
office and out-of-office BP measurements,
8-12
 the consequences of using ABPM for 
surveillance of high BP in the general population have not been fully explored. In fact, it has 
been recently proposed that ABPM should be included in the National Health and Nutrition 
Examination Survey (NHANES) of the United States, to more accurately classify 
hypertension prevalence and control.
13
 Furthermore, the National Institute for Health and 
Clinical Excellence (NICE) in the United Kingdom recommends the use of ABPM to 
confirm the diagnosis of hypertension for all patients with an office BP ≥140/90 mmHg.14 
The introduction of ABPM in the follow-up of subjects aged over 60 years from the 
Spanish Nutrition and Cardiovascular Risk Survey
15
 has provided us with the opportunity to 
examine how many people would change their BP status by using this technology in this 
general population setting. Like some other population surveys,
15-17
 
 
in this Spanish study 
casual BP was taken at subjects´ home, thus providing a more real measurement of BP 
because it is not so much affected by the alert reaction.
18
 Given that home BP measurement 
is increasingly used,
18,19
 and likely to keep rising in the next few years, especially for 
monitoring BP control, this is a scenario in which measuring the impact of using ABPM 
makes also sense. Thus, we estimated the impact of the ABPM on the prevalence and 
control of BP in older adults in Spain, the population group where hypertension is more 
frequent and challenging. This information is relevant from both a clinic and public health 
viewpoint, since a more accurate classification of the BP status would allow for quantifying 
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over- or under-treatment, and obtaining a balanced view of the burden of hypertension in the 
population.  
 
METHODS 
Study design and participants  
We conducted a cross-sectional analysis from the second wave of the Seniors-ENRICA 
study, a cohort set up in 2008-2010 with individuals selected through random sampling of 
the population aged ≥60 years in Spain.15 This second wave was conducted in 2012 among 
2519 individuals alive and included a phone interview on health status, lifestyle and 
morbidity, as well as a home visit to record BP and anthropometry, habitual diet and 
prescribed medication.  
Because of logistic and cost reasons, ABPM was offered to 1698 individuals, and 
ABPM was performed in 1328 subjects (response rate, 78.2%). Compared with subjects 
without ABPM, those who underwent it had similar age (71.8 vs. 71.7 years), proportion of 
males (47% vs. 49%), education level (63% vs. 61% with ≤primary studies), mean body 
mass index (27.8 vs. 27.5 kg/m
2
), proportion of diabetes (15.1% vs. 16.1%), current 
smoking (11.0% vs. 11.7), and previous history of cardiovascular disease (5.7% vs. 4.5%). 
Personnel involved in data collection received specific training in the study 
procedures. Study participants provided written consent and the study was approved by the 
clinical research ethics committee of the La Paz University Hospital in Madrid. 
 
Study variables  
Study participants reported their age, educational level, and smoking status. Weight and 
height were measured in each subject under standardized conditions. Body mass index 
(BMI) was calculated as weight in kg divided by height in m. Obesity was defined as BMI 
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≥30 kg/m2. Waist circumference (WC) was deemed to be located at the midpoint between 
the lowest rib and the iliac crest, and was measured with participants lightly clothed using a 
flexible, inelastic belt-type tape. Abdominal obesity was defined as WC >102 cm in men 
and >88 cm in women. Information on physical activity was obtained with the questionnaire 
used in the EPIC study that combines physical activity at work and at leisure time,
20
 and 
physical inactivity was defined as being inactive or moderately inactive. Participants also 
reported if they had ever being diagnosed with cardiovascular disease (CVD), diabetes, or 
hypertension. Medication use was collected by a face-to-face interview and verified against 
drug packaging during the home visits.  
 
Blood pressure measurement  
BP was measured by certified examiners using standardized procedures and conditions.
21
 
Casual BP was measured with validated automatic devices (Omron M6) and appropriate 
sized cuffs. BP was determined three times at 2-minute intervals, after resting 5 minutes in a 
seated position. In the analyses, casual BP was calculated as the mean of the last two of the 
three readings. 
Thereafter, 24-h ABPM was performed with a validated automated non-invasive 
oscillometric device (Microlife WatchBPO3 monitor, Microlife Corp, Switzerland),
22
 
programmed to register BP at 20-min intervals during the day and at 30-min during the night 
for the 24-h period. Appropriate cuff sizes were used. The majority of registries were 
performed on working days and the patients were instructed to maintain their usual activities 
but keeping the arm extended and immobile at the time of cuff inflation. The staff of the 
study returned to the patients’ homes for device removal the following day. Valid ABPM 
registries had to fulfill a series of pre-established criteria, including 24-h duration and at 
least 70% successful recordings of systolic BP (SBP) and diastolic BP (DBP) during the day 
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and night.
23,24
 Daytime and night-time periods were defined individually according to the 
patient’s self-reported time of going-to-bed and getting-up.  
Based on casual BP, hypertension was defined as mean SBP ≥140 mm Hg, DBP ≥90 
mm Hg, or currently taking prescribed antihypertensive medication.
23-26
 Treated 
hypertensive was defined as an affirmative answer to the following questions: “Were you 
prescribed an antihypertensive medication by your physician?” and “Are you currently 
taking this BP medication?” Among treated hypertensives, BP control was defined as SBP 
<140 and DBP <90 mm Hg, thresholds that were also used for identifying hypertension in 
untreated subjects. We chose this threshold since it corresponds to the universal definition of 
hypertension and BP target for all ages at the time of the survey,
25,26 
it is used in many 
population surveys,
15-17,27
 and has a consensus ABPM equivalent (130/80 mmHg for 24-h 
BP).
23-25
 Accordingly, ambulatory hypertension was defined as mean 24-h SBP ≥130 
mmHg, DBP ≥80 mmHg, or on current BP medication; this same value also corresponded to 
the treatment target. Treatment-eligible hypertension was defined as either BP above target 
or at goal BP under drug treatment. 
 
Statistical analyses  
A total of 1047 individuals with ≥70% valid ABPM readings and complete information on 
study´s variables were used for analysis (78.8% of all with available ABPM).  
We examined the relationship between casual and ambulatory BP through 
scatterplots supplemented with Bland-Altman plots.
28
 Then we classified individuals 
according to casual BP using two criteria: 1) BP categories (720 subjects with hypertension 
and 327 with normotension), and 2) antihypertensive drug treatment (514 treated 
hypertensives and 533 untreated subjects; the latter including 206 untreated hypertensives 
and 327 normotensives). We then calculated the percentage (and 95% confidence intervals) 
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of hypertensive subjects according to casual BP and to ABPM. Likewise, we calculated the 
percentage of subjects at BP goal according to casual BP and ABPM thresholds.
23-26
 
Although strictly speaking only treated subjects could meet BP goals, from a practical 
viewpoint untreated subjects were included in this definition since they could also be within 
(rather than achieve) the normal BP range. Next, we calculated the percentage of subjects 
reclassified from above casual BP goal to at 24-h BP goal, and those reclassified from at 
casual BP goal to above 24-h BP goal. Results were obtained for the total sample and also 
stratified by BP medication status. Lastly, we ran several sensitivity analyses to assess the 
robustness of the main results to alternative BP thresholds proposed by some authors for 
specific conditions. Thus, we used a casual BP threshold of 140/85 mmHg that some 
guidelines have recommended for people with diabetes.
23
 Second, despite BP at home was 
only measured in 1-ocassion, we also used the BP threshold of 135/85 mmHg suggested for 
definition of hypertension based on multiple BP readings at home over several days, and 
compared it with ambulatory daytime BP.
18
 Third, we made an additional sensitivity 
analysis using the recently proposed clinic BP goal of 150/90 mmHg for older people,
23,29 
and approaching its 24-h BP equivalent as 140/90 mmHg.
30
  
Data are presented as absolute frequencies and percentages for categorical variables 
and as mean ±standard deviation for continuous variables. Differences in sample 
characteristics between groups were assessed with the χ2 for categorical variables and the 
Student’s t test for continuous data. McNemar’s χ2 test was used to compare the proportion 
of subjects classified according to casual versus ABPM methods. Analyses were performed 
using the SPSS version 21, and statistical significance was set at P<0.05. 
 
RESULTS 
Sample characteristics  
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Table 1 shows the participants characteristics. Mean age of the 1047 individuals was 71.7 
years, 50.8% were males, mean BMI was 28.1 kg/m
2
, 14.9% had diabetes, and 5.7% had had 
previous CVD. Figure 1 displays the distribution of casual and ambulatory BP. Mean casual 
BP was 137.8/74.0 mmHg, mean 24-h BP was 123.6/69.8 mmHg, and mean daytime BP 
was 127.0/72.4 mmHg (Table 1). Both SBP and DBP distributions were bell-shaped. 
However, as expected in an old population, diastolic BP figures contributed much less than 
systolic to elevated BP. For example, 47.9% of subjects had casual SBP ≥140 mmHg, 26.9% 
had 24-h SBP ≥130, and 23.2% had daytime SBP ≥135. The corresponding percentage of 
subjects with casual DBP ≥90 mmHg, 24-h DBP ≥80, and daytime DBP ≥85 were 10.9%, 
7.4% and 4.5%, respectively.  
Hypertensive patients were older, with higher prevalence of obesity and diabetes 
than normotensives. Also, treated hypertensives were older, with higher mean BMI and 
higher frequency of obesity, diabetes and previous history of CVD than untreated subjects 
(Table 1). Mean casual and ambulatory SBP was higher in treated hypertensives than 
untreated participants (Table 1). However, compared with the 514 treated hypertensive 
patients, the 206 untreated hypertensive patients had higher mean casual and ambulatory BP 
(data not shown). Among treated patients, 36% were taking angiotensin-receptor blockers, 
23.9% ACE inhibitors, 17.3% calcium-channel blockers, 20% diuretics, 20.8% beta-
blockers, and 4.7% alpha-blockers. Overall, 56% of treated patients were on monotherapy, 
31% on 2 drugs, and 13% on 3 or more drugs.  
 
Relationship between casual and ambulatory blood pressure  
The scatter diagrams showed only moderate fitting to the regression line (Figure 2, panel a 
and b). Pearson correlation coefficients were also moderate: 0.62 (0.65 for untreated 
subjects and 0.56 for those treated) for the association between casual and 24-h SBP, and 
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0.56 for the association between casual and daytime SBP. Corresponding coefficients for 
DBP were similar (data not shown). The Bland-Altman plots of mean ambulatory SBP 
against the difference between casual and ambulatory SBP showed a marked overestimation 
bias (Figure 2, panel c and d). Mean difference between casual and 24-h SBP was 14.3 
mmHg (13.5 in untreated subjects and 15.1 in treated subjects), and 4.17 mmHg (4.18 in 
untreated and 4.16 in treated) for mean difference in casual vs 24-h DBP. Mean difference 
between casual and daytime SBP was 9.9 mmHg (1.6 for DBP).  
 
Prevalence of hypertension according to blood pressure measurement 
Based on only casual BP, the prevalence of hypertension was 68.8% (95% CI 66.0-71.6%), 
and it was 62.1% based on 24-h ABPM (95% CI 59.2-65.0%) (Table 2). The difference in 
hypertension prevalence between casual and 24-h BP generally remained across 
sociodemographic and cardiovascular risk factors like education level, obesity, physical 
inactivity, diabetes, smoking, and previous CVD (data not shown).  
 
Blood pressure reclassification according to treatment status 
A total of 206 (38.6%) untreated participants were above casual BP normal value, and 103 
of these (19.3% of all subjects) were above the 24-h normal value. Thus, 103 or 19.3% of all 
participants were above normal values under casual BP measurement and would be 
reclassified as at normal BP under ABPM (Table 3). Similarly, 245 (47.7%) treated subjects 
were above casual BP goal, and 121 of these (23.5% of all subjects) were above the 24-h 
goal. Thus, 124 (24.1% of all subjects) were above the goal under casual BP and would be 
reclassified as at BP goal under ABPM (Table 3).  
Likewise, 33 (6.2%) untreated participants had normal BP according to casual BP 
but would be reclassified as at above normal BP with ABPM, and 41 (8.0%) treated patients 
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were at goal under casual BP and would be reclassified as at above BP goal with ABPM 
(Table 3).  
Total reclassifications were 21.7% from above normal casual BP to at normal 24-h 
BP, and 7.1% from at normal casual BP to above normal 24-h BP (Table 3).  
 
Casual and 24-h blood pressure control 
A total of 596 subjects were within casual BP normal range, for either being normotensive 
or at treatment goal (56.9%, 95% CI 53.9%-59.9%), and 749 were at 24-h BP normal range 
or goal (71.5%, 95% CI 68.8-74.2%; absolute difference 14.6%, p<0.001). A breakdown by 
treatment status showed 327 untreated subjects at normal casual BP range (61.4%, 95% CI 
57.3-65.5%), and 397 at normal 24-h BP range (74.5%, 95% CI 70.8-78.2%; difference 
13.1%, p <0.001). On the other hand, 269 treated hypertensive patients were at casual BP 
goal (52.4%, 95% CI 48.1-56.7%), and 352 at 24-h BP goal (68.5%, 95% CI 64.5-72.5%; 
difference 16.1%, p<0.001).  
Lastly, 522 or 49.9% of all subjects (55.2% of untreated and 44.4% of treated) were 
within both normal casual and ambulatory BP ranges (Table 3).  
 
Treatment eligible hypertension and blood pressure control 
The 720 casual-BP-based hypertensives and the 650 24h-BP-based hypertensives were 
eligible for treatment. BP control among these patients with treatment-eligible hypertension 
increased from 37.4% (95% CI 33.9%-40.9%) under casual BP target to 54.1% (95% CI 
50.3%-57.9%) under 24-h ABPM target (absolute difference 16.7%, p<0.01) (Figure 3).  
Lastly, among subjects with BP above goal under casual BP target, 206 (45.7%) 
were not receiving antihypertensive medication treatment. Among subjects with BP above 
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goal under the 24-h ABPM target, 136 (45.6%) were not treated with antihypertensive 
medication.  
 
Sensitivity analyses  
Under the 140/85 mmHg casual BP threshold only for people with diabetes, main results 
remained materially unchanged (data not shown). Results were also similar when comparing 
casual BP (140/90 threshold) with ambulatory daytime target (135/85 mmHg) (Table 4). 
Interestingly, when using the 135/85 mmHg threshold for both casual and ambulatory 
daytime BP, we obtained an even greater difference in the frequency of hypertension 
between both measurement methods (74.5% vs 60.6%, or 13.9%) as compared with the 
difference based on main targets (6.7%), BP control among treated-eligible patients would 
double (26.3% vs 59.7%), and the total reclassification proportions (15.9% and 2%) would 
be moderately lower than those based on main targets (Table 4). Lastly, according to casual 
BP goal of 150/90 mmHg for older people (and 140/90 as 24-h BP equivalent), the 
difference in hypertension frequency based on casual BP (58.9%) versus 24-h BP (52.0%) 
was practically identical to that based on main thresholds used (6.7%), and the total 
reclassification proportions would then be 26.0% and 3.6%, close to those from the main 
targets considered (Table 4); however, control among treatment-eligible patients was much 
higher, thus a much larger number of patients would be seen as reaching target.  
 
DISCUSSION 
This contemporary population-based study has comprehensively quantified the proportion of 
older patients potentially affected by ABPM targets. It has shown that, the impact of using 
ABPM is appreciable. First, the prevalence of hypertension would be overestimated had BP 
status been assessed with casual BP instead of ABPM. Specifically, 6.7% or one in 15 
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hypertensive patients according to casual BP would not be considered hypertensive had 
ABPM been used, suggesting a considerable overdiagnosis when clinic BP is used alone. 
Extrapolating this 6.7% reduction to the older population of Spain in 2012,
31
 it would 
represent a reduction of approximately 700,000 older subjects classified as needing BP 
medication (7.5 million under casual BP and 6.8 million under the 24-h BP targets). In 
addition, the percentage of patients with treatment-eligible hypertension who met BP goals 
increased by 16.7% in absolute terms (one in 6 patients, or about 900,000 patients).  
Also, there was a considerable gap between the percentage of hypertensive patients 
at BP goal with ambulatory versus casual BP (16.1% or one additional hypertensive actually 
controlled in 6 treated patients). This conveys an optimistic message to physicians because 
when BP is measured more accurately, the degree of BP control achieved is clearly higher. 
However, overall only half of all subjects were at BP goal under both BP measurement 
techniques, which is important since some studies have shown that the ability to predict 
mortality was increased by the combination of in-office and out-of-office BP values.
32 
 
Discordance between casual and ambulatory BP. Clinical and public health 
implications  
Given the scarce concordance between casual and ambulatory BP, two main BP phenotypes 
emerge: white-coat (only casual BP above goal) and masked hypertension (only 24-h BP 
above goal) among untreated patients, and “office or casual resistance” and masked 
uncontrolled hypertension among treated patients.
4,19,23-25,322
 Nevertheless, we prefer to place 
the emphasis on patient reclassification to better appreciate the impact of using ABPM. One 
in 5 untreated subjects would be reclassified as not treatment-eligible, a concept that is 
consistent with the generally benign prognosis and conservative therapeutic approach in 
subjects with only casual BP elevated, at least in the absence of additional risk factors.
23,25,34
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Likewise, one in 4 treated patients would be reclassified as BP at goal, and thus might not 
need treatment intensification. Methodological differences aside, these proportions are 
moderately higher than those in other population-based studies,
8,19,23,25
 as corresponds to an 
older population.
19,23,25 
Interestingly, these proportions were lower than those obtained in 
Spanish older patients attending clinical settings,
35 
probably reflecting the minimization of 
the alert reaction in our study. On the other hand, assuming that only-24h BP elevated has a 
more serious prognosis and thus could deserve a more aggressive management,
23,25,34
 one in 
16 untreated subjects would be reclassified as treatment-eligible, and one in 12 treated 
patients would be reclassified as possibly needing intensification of treatment. The 
proportion of isolated ambulatory hypertension in this study is at the lower end of the range 
reported in other population studies,
8,9,12,19,23,25 
which is consistent with generally lower 
frequency in the elderly.
19,33,36 
Given the lack of clear indications for treatment of these 
discordant clinical entities,
23,25,34,37,38
 the therapeutic implications of reclassification have 
been presented only as an illustration of the potentially significant over- or under-treatment 
if using only a more inaccurate technique of measuring BP.  
Overall, the number of subjects who were still considered to have above-goal BP 
(28.5% of all subjects) outnumbered the number of subjects reclassified as at goal under 
ABPM target (21.7%), and almost half of subjects with BP above goal under either casual or 
24-h targets were untreated.  
All this supports the NICE statement on offering ABPM for the diagnosis of 
hypertension after an initial raised reading in the clinic; ABPM would reduce misdiagnosis, 
ensure the right people are treated with antihypertensives, and reduce the number of patients 
treated for hypertension.
14,39
 Although not universally accepted,
24
 this could save costs since 
the extra costs from ABPM are offset by cost savings from better targeted treatment.
40
 
Furthermore, ABPM is well tolerated by people, including the elderly.
41,42
 Likewise, given 
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these and other advantages of ABPM, some authors have proposed that the US Centers for 
Disease Control and Prevention include ABPM in the NHANES and that the US Food and 
Drug Administration (FDA) requires the use of ABPM as the gold standard for recording BP 
in randomized clinical trials.
43
 Yet it is well known that ABPM is not available to most 
patients with hypertension, and we might as well wonder if it will not take a medico-legal 
challenge to make the technique universally available. 
 
 
Methodological aspects 
Given that this study was not strictly representative of the general older population of Spain, 
extrapolations should be interpreted with caution. Nevertheless, the baseline 
sociodemographic and clinical characteristics of the participants at the inception of the 
cohort were reasonably similar to those who did not participate (age, 68.6 vs. 69.4 years; 
males, 48.1% vs. 45.0%; mean casual BP, 139.7/77.5 vs. 139.2/77.1 mmHg; mean BMI, 
28.6 vs. 28.6 kg/m
2
; diabetes, 15.2% vs. 18.0%; and previous CVD, 5.7% vs. 5.9%).  
Of note, like in some other population surveys,
15-17
 casual BP was not measured in 
the office but in subjects´ home,
 
thus probably diminishing a reaction alarm and giving more 
realistic estimates. However, only a few BP readings were taken on a single occasion by 
observers which were not familiar to the subjects. No doubt other methods such as 
automated office BP monitoring with the patient alone can also minimize anxiety-related 
increases in BP,
44 
and some population studies
 
have used office, home, and ABPM 
measurements.
8,9
 Nevertheless, the present study was specifically focused on the direct 
comparison between the two out-of-office BPs individually, which may provide a more 
accurate classification of the BP status. Given that the present analyses suggest that casual 
BP measurements are a biased estimate of ambulatory BP, it is likely that having multiple 
BP measurements would have not minimized the beneficial impact of ABPM.  
15 
 
 
 
The issue of selecting BP threshold is far from settled. Nevertheless, despite our 
results being sensitive to different BP thresholds, their direction is consistent. Under all 
alternative thresholds, casual BP overestimates the true (ambulatory) hypertension 
prevalence, greatly underestimated the BP control among treatment-eligible subjects, and 
upward and downward BP reclassification is noticeable. All this suggests the potential 
benefit of ABPM as compared with casual BP.  
Lastly, antihypertensive therapy was based on the participant´s declaration and 
therefore may be imprecise. Also, treatment adherence was not assessed, but it has been 
reported to be relatively high in Spain (68%).
45 
 
Conclusions  
We estimated that the application of ABPM would potentially reduce the number of older 
persons for whom hypertension therapy would be recommended by approximately 7%. In 
addition, about 17% of treatment-eligible patients would no longer be classified as having 
their BP poorly controlled, but instead would be considered adequately managed. This 
surely makes the case for ABPM mandatory in this age group. However, even under the 
ABPM target, over one fourth of older subjects with hypertension still have uncontrolled 
BP, and approximately half of them remain untreated. Reclassification of patients based on 
ABPM illustrates the clinical and public health implications of targeting treatment at 
patients who have actually elevated BP and avoiding treatment in those who don´t. All this 
supports the usefulness of measuring BP with ABPM.
46
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TABLE 1.Characteristics of the study participants. 
 All Hypertension status  Treatment status  
Variable  
N=1047 
Normotensive 
N=327 
Hypertensive 
N=720 
 
P* 
Untreated 
N=533 
Treated 
N=514 
 
P** 
Age, years 71.7±6.3 70.5±5.8 72.2±6.4 <0.001 70.9±6.3 72.5±6.3 <0.001 
Males, % 50.8 48.0 52.1 0.222 51.2 50.4 0.788 
≤Primary studies, % 61.4 61.8 61.3 0.872 59.3 63.6 0.150 
Casual SBP, mmHg 137.8±18.7 124.1±9.8 144.0±18.5 <0.001 135.5±18.2 140.2±18.9 <0.001 
Casual DBP, mmHg 74.0±10.3 70.1±8.2 75.8±10.6 <0.001 74.1±10.2 73.9±10.4 0.765 
24-h SBP, mmHg 123.6±11.4 117.3±9.9 126.4±10.9 <0.001 122.1±11.6 125.2±11.0 <0.001 
24-h DBP, mmHg 69.8±7.0 67.7±6.4 70.8±7.1 <0.001 69.9±7.2 69.7±6.8 <0.001 
Daytime SBP, mmHg  127.0±11.5 121.6±10.4 129.4±11.2 <0.001 126.1±11.8 127.9±11.2 0.012 
Daytime DBP, mmHg 72.4±7.5 70.7±6.9 73.2±7.6 <0.001 72.8±7.7 72.0±7.2 0.073 
BMI, kg/m
2
 28.1±4.6 27.1±4.1 28.6±4.7 <0.001 27.2±4.0 29.1±4.9 <0.001 
BMI ≥30 kg/m2, % 30.9 23.5 34.2 <0.001 23.5 38.5 <0.001 
WC ≥102/88cm, % 57.6 49.2 61.4 <0.001 50.3 65.2 <0.001 
Physical inactivity, % 41.0 39.1 41.8 0.417 40.3 41.6 0.670 
Diabetes mellitus, %  14.9 10.4 16.9 <0.001 10.9 19.1 <0.001 
Current smoking, % 11.1 11.6 10.8 0.762 13.3 8.8 0.06 
Previous CVD, % 5.7 6.1 5.6 0.718 4.1 7.4 0.023 
Abbreviations: BMI, body mass index; WC, waist circumference; CVD, cardiovascular disease. 
For definition of hypertension and treatment status, see the Methods section.  
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TABLE 2.Prevalence of hypertension
a 
according to casual and 24-h ambulatory blood pressure among 
older adults from the general population of Spain. 
  Based on casual 
blood pressure 
Based on 24-h blood 
pressure 
  
Characteristics N Percentage  
(95% CI) 
Percentage  
(95% CI) 
Absolute 
difference 
P  
value 
Total* 1047 68.8 (66.0-71.6) 62.1 (59.2-65.0) -6.7 0.009 
Gender      
Male 532 70.5 (66.6-74.4) 63.3 (59.2-67.4) -7.2 0.113 
Female 515 67.0 (62.9-71.1) 60.8 (56.6-65.0) -6.2 0.138 
Age      
<70years 470 63.2 (58.8-67.6) 54.7 (50.2-59.2) -8.5 0.101 
≥70 years 577 73.3 (69.7-76.9) 68.1 (64.3-71.9) -5.2 0.325 
Abbreviations.CI, confidence interval; CVD, cardiovascular disease. 
a
Hypertension: casual blood pressure 
(BP) ≥140/90 mmHg or on current BP medication, or 24-h BP ≥130/80 mmHg or on current BP 
medication. 
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TABLE 3. Reclassification of blood pressure control status according to ambulatory 
monitoring, by treatment status.  
 
  24-h blood pressure   
Casual blood pressure  <130/80 mmHg  ≥130/80 mmHg  Total 
  At casual and  
24-h BP goal 
 Reclassified to  
above 24-h BP goal 
 Not hypertensive  
or at casual BP goal 
<140/90 mmHg Total 522 (49.9%)  74 (7.1%)  596 (56.9%) 
 Untreated 294 (55.2%)  33 (6.2%)  327 (61.4%) 
 Treated 228 (44.4%)  41 (8.0%)  269 (52.3%) 
       
  Reclassified to  
at 24-h BP goal 
 Above casual and  
24-h BP goal 
  
Above casual BP goal 
≥140/90 mmHg Total 227 (21.7%)  224 (21.4%)  451 (43.1%) 
 Untreated 103 (19.3%)  103 (19.3%)  206 (38.6%) 
 Treated 124 (24.1%)  121 (23.5%)  245 (47.7%) 
       
Total Total 749 (71.5%)  298 (28.5%)  1047 (100.0%) 
 Untreated 397 (74.5%)  136 (25.5%)  533 (100.0%) 
 Treated 352 (68.5%)  162 (31.5%)  514 (100.0%) 
Abbreviations. BP, blood pressure. Untreated: normotensive and untreated hypertensive individuals. Treated: 
hypertensive patients on current BP medication. 
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Table 4. Impact of different blood pressure thresholds on the prevalence and control of hypertension.  
 
 
Blood pressure criteria 
Prevalence 
of hypertension
a 
Blood pressure 
at goal
b 
Reclassified to at 
ambulatory BP goal
c 
Reclassified to above 
ambulatory BP goal
d 
Casual BP (140/90 mmHg) 720 (68.8%) 269 (37.4%) 227 (21.7%) 74 (7.1%) 
24-h BP (130/80 mmHg)  650 (62.1%) 352 (54.1%)   
     
Casual BP (140/90 mmHg) 720 (68.8%) 269 (37.4%) 266 (25.4%) 71 (6.8%) 
Daytime BP (135/85 mmHg) 635 (60.6%) 379 (59.7%)   
     
Casual BP (135/85 mmHg) 780 (74.5%) 205 (26.3%) 166 (15.9%) 21 (2.0%) 
Daytime BP (135/85 mmHg) 635 (60.6%) 379 (59.7%)   
     
Casual BP (150/90 mmHg) 617 (58.9%) 301 (48.8%) 272 (26.0%) 38 (3.6%) 
24-h BP (140/90 mmHg)  544 (52.0%) 462 (84.9%)   
a
Hypertension: casual blood pressure (BP) above goal or on current BP medication, or 24-h BP above goal or 
on current BP medication.  
b
Percentage of subjects with treatment-eligible hypertension with BP at goal, according to casual and 
ambulatory BP. Medication-eligible hypertension is defined as receiving treatment or above goal for each 
casual BP and ambulatory BP target.  
c
Reclassification of individuals from above goal under casual BP to at goal under ambulatory BP.  
d
Reclassification of individuals from at goal under casual BP to above goal under ambulatory BP. 
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Figures legends.  
FIGURE 1. Distribution of casual, 24-hour, and daytime systolic blood pressure.  
FIGURE 2. Scatterplots (panel a and b) and Bland-Altman plots (panel c and d) for the 
association between casual and ambulatory systolic blood pressure.  
In panel a and b, solid circles represent treated subjects, and unfilled circles represent untreated 
subjects. In panel c and d, the solid line indicates the mean SBP difference, and dashed lines 
indicate the 95% limits of agreement (two standard deviations around the mean difference).  
FIGURE 3. Number of subjects eligible for medication treatment, and percentage of subjects 
with treatment-eligible hypertension with BP at goal, according to casual and 24-h BP. 
Medication-eligible hypertension is defined as receiving treatment or above goal for each casual BP 
and 24-h BP target. Bars: 95% confidence intervals for percentage estimates of BP at goal.  
Casual BP at goal: <140/90 mmHg. 24-h BP at goal: <130/80 mmHg.  
